4 articles
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...
Personalized mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial A personalized mRNA cancer vaccine developed by pharmaceutical giants Merck and Moderna has shown significant...
The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...